These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Prognostic Value of Plasma hPG Kohli M; Tan W; Vire B; Liaud P; Blairvacq M; Berthier F; Rouison D; Garnier G; Payen L; Cousin T; Joubert D; Prieur A Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33498444 [TBL] [Abstract][Full Text] [Related]
6. hPG Chauhan A; Prieur A; Kolesar J; Arnold S; Payen L; Mahi Y; Vire B; Sands M; Evers BM; Joubert D; Anthony L Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205614 [TBL] [Abstract][Full Text] [Related]
7. Association between post-operative hPG Doucet L; Cailleteau A; Vaugier L; Gourmelon C; Bureau M; Salaud C; Roualdes V; Samarut E; Aumont M; Zenatri M; Loussouarn D; Quillien V; Bocquet F; Payen-Gay L; Joubert D; Prieur A; Robert M; Frenel JS ESMO Open; 2023 Oct; 8(5):101626. PubMed ID: 37713930 [TBL] [Abstract][Full Text] [Related]
8. hPG Casile M; Passildas J; Vire B; Molnar I; Durando X Front Neurol; 2022; 13():1073476. PubMed ID: 36712425 [TBL] [Abstract][Full Text] [Related]
9. A novel method to detect hPG Cappellini M; Flaceliere M; Saywell V; Soule J; Blanc E; Belouin F; Ortiz E; Canterel-Thouennon L; Poupeau S; Tigrett S; Vire B; Liaud P; Blairvacq M; Joubert D; Prieur A Anal Methods; 2021 Oct; 13(38):4468-4477. PubMed ID: 34494619 [TBL] [Abstract][Full Text] [Related]
10. Identification and validation of novel prognostic markers in Renal Cell Carcinoma. Rabjerg M Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890 [TBL] [Abstract][Full Text] [Related]
11. Progastrin: An Overview of Its Crucial Role in the Tumorigenesis of Gastrointestinal Cancers. Fioretzaki R; Sarantis P; Charalampakis N; Christofidis K; Mylonakis A; Koustas E; Karamouzis MV; Sakellariou S; Schizas D Biomedicines; 2024 Apr; 12(4):. PubMed ID: 38672239 [TBL] [Abstract][Full Text] [Related]
12. Detection of p53 Mutations in Circulating DNA of Transplanted Hepatocellular Carcinoma Patients as a Biomarker of Tumor Recurrence. García-Fernández N; Macher HC; Rubio A; Jiménez-Arriscado P; Bernal-Bellido C; Bellido-Díaz ML; Suárez-Artacho G; Guerrero JM; Gómez-Bravo MA; Molinero P Adv Exp Med Biol; 2016; 924():25-28. PubMed ID: 27753013 [TBL] [Abstract][Full Text] [Related]
13. Clinicopathological and Prognostic Value of Plasma CD24 Level in Hepatocellular Carcinoma. Maimaitiming A; Zhou X; Ma X; Huang Y; Wang Q; Deng R; Ren Y; Chai X; Zhang P J Invest Surg; 2020 Jul; 33(6):536-541. PubMed ID: 30543135 [No Abstract] [Full Text] [Related]
14. Revealing the clinical significance and prognostic value of small nucleolar RNA SNORD31 in hepatocellular carcinoma. Ding Y; Sun Z; Zhang S; Xu Q; Zhou L; Zhou D; Li Y; Han X; Xu H; Bai Y; Xu C; Ding H; Ge Y; Wang W Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32697317 [TBL] [Abstract][Full Text] [Related]
15. Impact of circulating tumor DNA in hepatocellular and pancreatic carcinomas. Dhayat SA; Yang Z J Cancer Res Clin Oncol; 2020 Jul; 146(7):1625-1645. PubMed ID: 32338295 [TBL] [Abstract][Full Text] [Related]
16. The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinoma. Trevisan França de Lima L; Broszczak D; Zhang X; Bridle K; Crawford D; Punyadeera C Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188451. PubMed ID: 33065194 [TBL] [Abstract][Full Text] [Related]
17. TRIB3 promotes hepatocellular carcinoma growth and predicts poor prognosis. Wang XJ; Li FF; Zhang YJ; Jiang M; Ren WH Cancer Biomark; 2020; 29(3):307-315. PubMed ID: 32716348 [TBL] [Abstract][Full Text] [Related]
18. A novel multimarker assay for the phenotypic profiling of circulating tumor cells in hepatocellular carcinoma. Court CM; Hou S; Winograd P; Segel NH; Li QW; Zhu Y; Sadeghi S; Finn RS; Ganapathy E; Song M; French SW; Naini BV; Sho S; Kaldas FM; Busuttil RW; Tomlinson JS; Tseng HR; Agopian VG Liver Transpl; 2018 Jul; 24(7):946-960. PubMed ID: 29624843 [TBL] [Abstract][Full Text] [Related]
19. A re-emerging marker for prognosis in hepatocellular carcinoma: the add-value of fishing c-myc gene for early relapse. Pedica F; Ruzzenente A; Bagante F; Capelli P; Cataldo I; Pedron S; Iacono C; Chilosi M; Scarpa A; Brunelli M; Tomezzoli A; Martignoni G; Guglielmi A PLoS One; 2013; 8(7):e68203. PubMed ID: 23874541 [TBL] [Abstract][Full Text] [Related]
20. Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature. Qin LX; Tang ZY J Cancer Res Clin Oncol; 2004 Sep; 130(9):497-513. PubMed ID: 15205947 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]